drugset
drugset / Trial / NCT05029297

Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.

NCT05029297 ↗

Phase 3 Completed 161 enrolled Arafarma Group, S.A. Fundación Teófilo Hernando, Spain · collab
RandomizedCrossoverOpen-labelTreatment

Summary

Clinical trial of "line extension" of drug ARAFARMADOL® 0.075% cream in a new formulation in topical solution applicable in roll-on and with the same therapeutic indications approved for the cream.

Timeline

Start
2010-11-04
Primary completion
2018-10-23
Completion
2018-10-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 0.075 % Topical
Subject Capsaicin Small molecule 0.75 unknown Topical

Indications

diabetic neuropathy